Nurse Prescribers with Davis Edge
6th Edition
TEST BANK
Reference: Ch. 1, Section: Scope of Practice & Legal
Responsibilities
Question Stem: An APRN in a state with collaborative practice
requirements is asked by a clinic manager to begin prescribing
independently while the clinic finalizes a collaborative
agreement. What is the APRN’s best immediate action?
A. Begin prescribing; document the manager’s verbal approval.
B. Wait to prescribe until the formal collaborative agreement is
executed.
C. Prescribe only over-the-counter medications until the
agreement is signed.
D. Ask a physician colleague to sign off on prescriptions
retroactively.
Correct Answer: B
Rationale (Correct): The APRN must practice within
legal/regulatory requirements; prescribing without a valid
collaborative agreement violates scope-of-practice laws and
risks patient safety and legal consequences. This aligns with
,chapter emphasis on legal responsibilities.
brochures.fadavis.com+1
Rationale (A): Verbal managerial approval does not supersede
statutory or regulatory requirements; documentation alone
doesn't authorize independent prescribing.
Rationale (C): OTC recommendations may be appropriate
clinically but do not replace the need to follow state prescribing
rules for prescription medications.
Rationale (D): Retroactive sign-off does not make prior
unauthorized prescribing lawful and may still violate
regulations.
Teaching Point: Always verify and comply with current state
scope-of-practice and collaborative agreement requirements.
Citation: Woo & Wright, Pharmacotherapeutics for Advanced
Practice Nurse Prescribers, Ch. 1 (Scope & legal responsibility).
brochures.fadavis.com+1
2.
Reference: Ch. 1, Section: Prescribing Authority & Regulatory
Oversight
Question Stem: When an APRN prescriber registers with the
DEA to prescribe controlled substances, which obligation is
primary regarding controlled substance records?
A. Keep informal notes only in the chart.
B. Maintain accurate, retrievable records and comply with state
and federal reporting.
,C. Rely solely on pharmacy records for controlled-substance
documentation.
D. Destroy older controlled-substance records after one year.
Correct Answer: B
Rationale (Correct): APRNs must maintain accurate, retrievable
prescriptions and documentation and follow state/federal
reporting (e.g., PDMPs, DEA rules), as emphasized in prescribing
oversight content. F. A. Davis+1
Rationale (A): Informal notes are insufficient; legal
requirements demand formal, retrievable records.
Rationale (C): Pharmacy records complement but do not
replace the prescriber’s legal documentation responsibilities.
Rationale (D): Record retention requirements are longer and
vary by jurisdiction; destroying records after one year can
violate laws.
Teaching Point: Keep complete, retrievable controlled-
substance records per DEA and state rules.
Citation: Woo & Wright, Ch. 1 (Prescribing authority; controlled
substances). F. A. Davis+1
3.
Reference: Ch. 1, Section: Collaborative Practice Agreements
(CPAs)
Question Stem: An APRN and collaborating physician are
drafting a CPA. Which element is essential to include to ensure
safe prescribing practice?
, A. A list of medications the APRN may never order.
B. Clear delineation of prescriptive authority, supervision level,
and protocols for referrals.
C. A clause allowing verbal overrides by the physician without
documentation.
D. A universal template with no local adaptation.
Correct Answer: B
Rationale (Correct): Effective CPAs define prescriptive authority,
supervision, and referral protocols to protect patient safety and
legal compliance; the textbook highlights clarity in CPAs.
brochures.fadavis.com+1
Rationale (A): A prohibitive list alone is insufficient; CPAs should
be comprehensive and describe scope and processes.
Rationale (C): Allowing undocumented verbal overrides
undermines accountability and safe practice.
Rationale (D): Templates require adaptation to local laws and
practice realities; one-size-fits-all is unsafe.
Teaching Point: CPAs must clearly define roles, authority, and
processes.
Citation: Woo & Wright, Ch. 1 (Collaborative practice
agreements). brochures.fadavis.com+1
4.
Reference: Ch. 1, Section: Ethical & Professional Responsibilities
Question Stem: A patient requests an off-label medication that
has emerging evidence but limited regulatory approval for their